'Covid is not going away': Virologist fund manager Dr Ogden on coronavirus, healthcare valuations and biotech opportunities

Single vaccine 'not enough' to treat patients

Lauren Mason
Platinum Asset Management's Dr Bianca Ogden

Platinum Asset Management's Dr Bianca Ogden

The coronavirus pandemic has changed how the world's healthcare systems and biotechnology companies will operate irrevocably as Covid-19 "isn’t going to go away", according to virologist and manager of the AUS$335m Platinum International Healthcare fund Dr Bianca Ogden.

Ogden, who obtained a PhD in virology, and previously worked as a scientist for Johnson & Johnson and Novartis before launching the portfolio in 2003, said comparisons can be made between the Covid-19...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space

  • Get ahead of regulatory and technological changes affecting fund management

  • Important and breaking news stories selected by the editors delivered straight to your inbox each day

  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts

  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Markets

Market Movers Blog: OPEC to monitor pandemic closely as it agrees to maintain output hike

Market Movers Blog: US sees job growth below expectations for November

Latest news and analysis

Investment Week
clock 03 December 2021 • 1 min read
AJ Bell annual profits up 13% to £55m

AJ Bell annual profits up 13% to £55m

Annual results for year ended 30 September

Jenna Brown
clock 02 December 2021 • 3 min read
All the latest news, analysis and content about the Covid-19 outbreak

Coronavirus Blog: UK buys 114 million more vaccine doses to tackle Omicron variant

Latest news and reaction

Investment Week
clock 02 December 2021 • 1 min read